1. Home
  2. RDY vs PFS Comparison

RDY vs PFS Comparison

Compare RDY & PFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • PFS
  • Stock Information
  • Founded
  • RDY 1984
  • PFS 1839
  • Country
  • RDY India
  • PFS United States
  • Employees
  • RDY N/A
  • PFS N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • PFS Savings Institutions
  • Sector
  • RDY Health Care
  • PFS Finance
  • Exchange
  • RDY Nasdaq
  • PFS Nasdaq
  • Market Cap
  • RDY 2.1B
  • PFS 2.4B
  • IPO Year
  • RDY N/A
  • PFS N/A
  • Fundamental
  • Price
  • RDY $14.53
  • PFS $18.64
  • Analyst Decision
  • RDY Strong Buy
  • PFS Strong Buy
  • Analyst Count
  • RDY 2
  • PFS 5
  • Target Price
  • RDY $16.95
  • PFS $23.60
  • AVG Volume (30 Days)
  • RDY 1.5M
  • PFS 666.6K
  • Earning Date
  • RDY 07-28-2025
  • PFS 07-24-2025
  • Dividend Yield
  • RDY 0.56%
  • PFS 5.17%
  • EPS Growth
  • RDY 1.47
  • PFS N/A
  • EPS
  • RDY 0.79
  • PFS 1.19
  • Revenue
  • RDY $3,809,801,863.00
  • PFS $700,486,000.00
  • Revenue This Year
  • RDY $10.24
  • PFS $26.03
  • Revenue Next Year
  • RDY N/A
  • PFS $7.82
  • P/E Ratio
  • RDY $18.39
  • PFS $15.61
  • Revenue Growth
  • RDY 16.61
  • PFS 58.68
  • 52 Week Low
  • RDY $12.26
  • PFS $14.34
  • 52 Week High
  • RDY $16.89
  • PFS $22.24
  • Technical
  • Relative Strength Index (RSI)
  • RDY 37.98
  • PFS 64.68
  • Support Level
  • RDY $14.81
  • PFS $17.40
  • Resistance Level
  • RDY $15.25
  • PFS $18.93
  • Average True Range (ATR)
  • RDY 0.20
  • PFS 0.47
  • MACD
  • RDY -0.12
  • PFS 0.13
  • Stochastic Oscillator
  • RDY 5.18
  • PFS 86.72

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About PFS Provident Financial Services Inc

Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The Company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The Company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The Company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.

Share on Social Networks: